---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-000583"
form_type: "8-K"
ticker: "CNBX"
cik: "0001343009"
company_name: "CNBX Pharmaceuticals Inc."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:12:44.115132+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CNBX Pharmaceuticals enters convertible note with $55K initial, up to $850K, 35% discount conversion

## Summary
- Issue Date Jan 23, 2025; maturity Oct 30, 2025; 10% interest, 9% OID, default interest 22%.
- Conversion price at 65% of market price (35% discount), exercisable from day 180.
- Company may prepay at 110%-130% of face during first 180 days; later subject to holder agreement.
- Company must register all shares; holder prohibited from short-selling during term.
- Institutional investor 1800 Diagonal Lending LLC provided $55,000, with potential up to $850,000.

## SEC filing metadata
- accession: 0001683168-25-000583
- form_type: 8-K
- ticker: CNBX
- cik: 0001343009
- company_name: CNBX Pharmaceuticals Inc.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1343009/000168316825000583/0001683168-25-000583-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1343009/000168316825000583/cnbx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-000583
- JSON: https://secwatch.observer/filing/0001683168-25-000583.json
- Plain text: https://secwatch.observer/filing/0001683168-25-000583.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.